QIAGEN OmicSoft and Biomedical Knowledge Base

Discoveries from public immuno-oncology studies using Omicsoft and Ingenuity Pathway Analysis

174 views
January 12, 2023
This training will focus on how QIAGEN Omicsoft Studio and Ingenuity Pathway Analysis (IPA) can be used to discover new biomarkers, validate (or study) drug targets and identify novel mechanism of action with user and/or public Immuno-Oncology studies from resources like GEO, SRA, TCGA and more.
Attendees will learn how to
• Investigate expression of a gene/biomarker/drug target across different treatments and diseases
• Derive a biomarker/gene signature from specific condition (example non-responders of a drug, a specific disease/disease subtype and more)
• Correlate expression of multiple genes and biomarkers
• Compare different experimental groups (user and/or public data) at both gene expression and pathways/regulatory networks activity levels

Related videos

QIAGEN OmicSoft and Biomedical Knowledge Base

Drug treatment, toxicology and target safety assessment using QIAGEN IPA and OmicSoft

271 views December 01, 2022

In this 90-minute training, you’ll learn how to do drug treatment, toxicology...

QIAGEN OmicSoft and Biomedical Knowledge Base

Checkpoint inhibitors investigation in context of biomarkers, drug targets and pathways using...

283 views September 15, 2022

This training will focus on how QIAGEN Omicsoft Studio and IPA can be used to...

QIAGEN OmicSoft and Biomedical Knowledge Base

Drug Target and Biomarker Investigation using OmicSoft OncoLand

442 views February 01, 2022

In this 90-minute training, attendees will learn how to use basic expression...

QIAGEN OmicSoft and Biomedical Knowledge Base

QIAGEN Biomedical KB-HD: data- and analytics-driven drug discovery

21 views May 23, 2024

Ingenuity Pathway Analysis (IPA), currently cited in tens of thousands of...